{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:51:27Z","timestamp":1773071487532,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.suc.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T18:38:49Z","timestamp":1572633529000},"page":"13-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Role of Heredity in Melanoma Susceptibility"],"prefix":"10.1016","volume":"100","author":[{"given":"James F.","family":"Abdo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayush","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2019.09.006_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/1097-0142(196605)19:5<607::AID-CNCR2820190502>3.0.CO;2-8","article-title":"On the antiquity of melanoma","volume":"19","author":"Urteaga","year":"1966","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.006_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CMR.0b013e328351fa4d","article-title":"A\u00a0brief history of melanoma: from mummies to mutations","volume":"22","author":"Rebecca","year":"2012","journal-title":"Melanoma Res"},{"key":"10.1016\/j.suc.2019.09.006_bib3","series-title":"The emperor of all maladies: a biography of cancer","author":"Mukherjee","year":"2010"},{"key":"10.1016\/j.suc.2019.09.006_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.5694\/j.1326-5377.1956.tb36084.x","article-title":"Some geographical aspects of the mortality from melanoma in Europeans","volume":"1","author":"Lancaster","year":"1956","journal-title":"Med J Aust"},{"key":"10.1016\/j.suc.2019.09.006_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2010.11.040","article-title":"Melanocortin MC1 receptor in human genetics and model systems","volume":"660","author":"Beaumont","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.suc.2019.09.006_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte\u2013stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jmg.15.5.352","article-title":"Familial atypical multiple mole-melanoma syndrome","volume":"15","author":"Lynch","year":"1978","journal-title":"J\u00a0Med Genet"},{"issue":"15","key":"10.1016\/j.suc.2019.09.006_bib8","first-page":"210","article-title":"Update in genetic susceptibility in melanoma","volume":"3","author":"Potrony","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.suc.2019.09.006_bib9","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.suc.2019.09.006_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","article-title":"A\u00a0novel recurrent mutation in MITF predisposes to familial and sporadic melanoma","volume":"480","author":"Yokoyama","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.suc.2019.09.006_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2015.08.038","article-title":"Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome","volume":"74","author":"Soura","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib12","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.suc.2019.09.006_bib13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.137.11.1493","article-title":"Genetic epidemiology of cutaneous melanoma: a global perspective","volume":"137","author":"Goldstein","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib15","first-page":"889","article-title":"Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families","volume":"9","author":"Goldstein","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.suc.2019.09.006_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1523-1747.2000.00823.x","article-title":"Genotype\/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations","volume":"114","author":"Bishop","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jaad.2015.09.070","article-title":"Familial skin cancer syndromes: increased melanoma risk","volume":"74","author":"Ransohoff","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1523-1747.1998.00185.x","article-title":"Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994","volume":"110","author":"Hille","year":"1998","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0959-8049(03)00313-7","article-title":"Genetic epidemiology of melanoma","volume":"39","author":"Bataille","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.suc.2019.09.006_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00019606-199704000-00003","article-title":"Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma","volume":"6","author":"Moskaluk","year":"1997","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.suc.2019.09.006_bib21","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","article-title":"Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-leiden)-positive melanoma families","volume":"14","author":"De Snoo","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2019.09.006_bib22","doi-asserted-by":"crossref","first-page":"677.e14","DOI":"10.1016\/j.jaad.2009.03.016","article-title":"Selection criteria for genetic assessment of patients with familial melanoma","volume":"61","author":"Leachman","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib23","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.suc.2019.09.006_bib24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.suc.2019.09.006_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.suc.2019.09.006_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.suc.2019.09.006_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.2941","article-title":"Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma","volume":"46","author":"Shi","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib28","article-title":"Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma","volume":"107","author":"Aoude","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.suc.2019.09.006_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2015.08.037","article-title":"Hereditary melanoma: update on syndromes and management: emerging melanoma cancer complexes and genetic counseling","volume":"74","author":"Soura","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archderm.1978.01640170032006","article-title":"Origin of familial malignant melanomas from heritable melanocytic lesions: the BK mole syndrome","volume":"114","author":"Clark","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","article-title":"Melanoma genetics","volume":"53","author":"Read","year":"2016","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","article-title":"Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations","volume":"11","author":"Moran","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1016\/j.suc.2019.09.006_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","article-title":"PTEN: one gene, many syndromes","volume":"22","author":"Eng","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.suc.2019.09.006_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.suc.2019.09.006_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.suc.2019.09.006_bib36","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/jdv.13665","article-title":"Differential diagnosis of spitzoid melanocytic neoplasms","volume":"30","author":"Stefanaki","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3, Part 2","key":"10.1016\/j.suc.2019.09.006_bib37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/jid.2011.426","article-title":"Shining a light on xeroderma pigmentosum","volume":"132","author":"DiGiovanna","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.2010.083022","article-title":"Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair","volume":"48","author":"Bradford","year":"2011","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1524-4725.1983.tb00869.x","article-title":"Dysplastic nevi as precursors to hereditary melanoma","volume":"9","author":"Kraemer","year":"1983","journal-title":"J\u00a0Dermatol Surg Oncol"},{"key":"10.1016\/j.suc.2019.09.006_bib40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2019.09.006_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jmedgenet-2012-101455","article-title":"Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants","volume":"50","author":"Puntervoll","year":"2013","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib42","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-05-0321A","article-title":"Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations","volume":"14","author":"Goldstein","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.suc.2019.09.006_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jid.2013.272","article-title":"Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients","volume":"134","author":"Sturm","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib44","first-page":"1298","article-title":"Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families","volume":"54","author":"Birch","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.suc.2019.09.006_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archdermatol.2010.428","article-title":"Multiple primary cutaneous melanomas in Li-Fraumeni syndrome","volume":"147","author":"Curiel-Lewandrowski","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib46","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00432-002-0360-3","article-title":"p53 germline mutation in a patient with Li-Fraumeni syndrome and three metachronous malignancies","volume":"128","author":"P\u00f6tzsch","year":"2002","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.suc.2019.09.006_bib47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jmg.24.11.664","article-title":"Malignant melanoma in families of children with osteosarcoma, chondrosarcoma, and adrenal cortical carcinoma","volume":"24","author":"Hartley","year":"1987","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00439-009-0715-9","article-title":"Genetic risk factors for melanoma","volume":"126","author":"Meyle","year":"2009","journal-title":"Hum Genet"},{"key":"10.1016\/j.suc.2019.09.006_bib50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamaoto.2016.0230","article-title":"Changing trends in the incidence of thyroid cancer in the United States","volume":"142","author":"Morris","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.suc.2019.09.006_bib51","doi-asserted-by":"crossref","first-page":"1046.e2","DOI":"10.1016\/j.jaad.2015.02.1113","article-title":"Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma","volume":"72","author":"Kim","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib52","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600\u2013mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2019.09.006_bib53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/jid.2009.287","article-title":"Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations","volume":"130","author":"Jovanovic","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.suc.2019.09.006_bib54","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.2147\/OTT.S117121","article-title":"NRAS-mutant melanoma: current challenges and future prospect","volume":"10","author":"Mu\u00f1oz-Couselo","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.suc.2019.09.006_bib55","first-page":"6","article-title":"Constitutive activation of the ras-raf signaling pathway in metastatic melanoma is associated with poor prognosis","volume":"3","author":"Houben","year":"2004","journal-title":"J\u00a0Carcinog"},{"key":"10.1016\/j.suc.2019.09.006_bib56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2019.09.006_bib57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.suc.2019.09.006_bib58","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: from mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.suc.2019.09.006_bib59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0000000000000051","article-title":"Recent developments in prognostic and predictive testing in uveal melanoma","volume":"25","author":"Field","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"issue":"8","key":"10.1016\/j.suc.2019.09.006_bib60","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/1097-0142(19801015)46:8<1787::AID-CNCR2820460816>3.0.CO;2-S","article-title":"Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma","volume":"46","author":"Elder","year":"1980","journal-title":"\u201dCancer"},{"key":"10.1016\/j.suc.2019.09.006_bib61","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1200\/JCO.2013.51.3002","article-title":"Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study","volume":"31","author":"Thomas","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2019.09.006_bib62","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/0008-5472.CAN-09-2653","article-title":"Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.suc.2019.09.006_bib63","unstructured":"National comprehensive cancer network screening recommendations for BRCA-Related Breast and\/or Ovarian Cancer Syndromes. 2019. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed October 24, 2019."},{"issue":"6","key":"10.1016\/j.suc.2019.09.006_bib64","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0190-9622(93)70279-3","article-title":"How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?","volume":"29","author":"Newton","year":"1993","journal-title":"J Am Acad Dermatol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610919301240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610919301240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:10:48Z","timestamp":1758539448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610919301240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0039610919301240"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.006","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Heredity in Melanoma Susceptibility","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}